(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

RYZUMVI

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

RYZUMVI

ST13

US500000097979106

Class

5

Filing

97979106

Registration

7581889

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

25

Latest update

02/26/2025

Trademark type

Word

Nice classes

5

Filing date

10/10/2022

Registration date

11/26/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/26/2024

Last transaction

02/26/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

04/01/2024

First use in commerce

04/01/2024

Drawing code

4

Owner type

03

Owner location

DURHAM, NC

Examiner

ROSSMAN, WILLIAM

Law office

L90

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

OPUS GENETICS, INC.
OCUPHIRE PHARMA, INC.

Representatives

Glenn A. Gundersen DECHERT LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

PHARMACEUTICAL PRODUCTS FOR OPHTHALMOLOGICAL USE; PHARMACEUTICAL PREPARATIONS FOR THE PREVENTION AND TREATMENT OF EYE DISEASES AND CONDITIONS

Publications

History of USPTO decisions and trademark events.

25 publications found

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

02/26/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

11/26/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

11/26/2024

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

11/05/2024

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

11/05/2024

SUPC

STATEMENT OF USE PROCESSING COMPLETE

10/23/2024

DPCC

DIVISIONAL PROCESSING COMPLETE

10/23/2024

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

10/23/2024

IUAF

USE AMENDMENT FILED

05/07/2024

DRRR

DIVISIONAL REQUEST RECEIVED

05/07/2024

ERTD

TEAS REQUEST TO DIVIDE RECEIVED

05/07/2024

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

01/30/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/05/2023

PUBO

PUBLISHED FOR OPPOSITION

12/05/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/15/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/27/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/26/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/25/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/25/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

07/28/2023

GNRT

NON-FINAL ACTION E-MAILED

07/28/2023

CNRT

NON-FINAL ACTION WRITTEN

07/28/2023

DOCK

ASSIGNED TO EXAMINER

07/24/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/25/2022

NWAP

NEW APPLICATION ENTERED

10/13/2022

Continuous trademark protection

Get notified about every new filing that threatens RYZUMVI or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.